These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38700026)
21. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines. Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096 [TBL] [Abstract][Full Text] [Related]
22. Characterization and stability of nanostructured lipid carriers as drug delivery system. Abbasalipourkabir R; Salehzadeh A; Abdullah R Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544 [TBL] [Abstract][Full Text] [Related]
23. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546 [TBL] [Abstract][Full Text] [Related]
24. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs. Shah RM; Eldridge DS; Palombo EA; Harding IH Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371 [TBL] [Abstract][Full Text] [Related]
25. Skin Delivery and in Vitro Biological Evaluation of Trans-Resveratrol-Loaded Solid Lipid Nanoparticles for Skin Disorder Therapies. Rigon RB; Fachinetti N; Severino P; Santana MH; Chorilli M Molecules; 2016 Jan; 21(1):E116. PubMed ID: 26805794 [TBL] [Abstract][Full Text] [Related]
26. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma. Pandey V; Gajbhiye KR; Soni V Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582 [TBL] [Abstract][Full Text] [Related]
27. Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity. Singh G; Nenavathu BP; Imtiyaz K; Moshahid A Rizvi M Biomed Pharmacother; 2020 Sep; 129():110443. PubMed ID: 32593130 [TBL] [Abstract][Full Text] [Related]
28. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs. Kumar R; Singh A; Garg N; Siril PF Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of in-vitro cytotoxicity and cellular uptake efficiency of zidovudine-loaded solid lipid nanoparticles modified with Aloe Vera in glioma cells. K S J; Sharma CP; Kalarikkal N; Sandeep K; Thomas S; Pothen LA Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():40-50. PubMed ID: 27207037 [TBL] [Abstract][Full Text] [Related]
30. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Liu CH; Wu CT; Fang JY Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495 [TBL] [Abstract][Full Text] [Related]
31. The Effect of Millisecond Pulsed Electric Fields (msPEF) on Intracellular Drug Transport with Negatively Charged Large Nanocarriers Made of Solid Lipid Nanoparticles (SLN): In Vitro Study. Kulbacka J; Pucek A; Wilk KA; Dubińska-Magiera M; Rossowska J; Kulbacki M; Kotulska M J Membr Biol; 2016 Oct; 249(5):645-661. PubMed ID: 27173678 [TBL] [Abstract][Full Text] [Related]
33. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859 [TBL] [Abstract][Full Text] [Related]
34. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles. Kumar R; Singh A; Sharma K; Dhasmana D; Garg N; Siril PF Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110184. PubMed ID: 31753394 [TBL] [Abstract][Full Text] [Related]
35. Intranasal solid lipid nanoparticles for management of pain: A full factorial design approach, characterization & Gamma Scintigraphy. Khanna K; Sharma N; Rawat S; Khan N; Karwasra R; Hasan N; Kumar A; Jain GK; Nishad DK; Khanna S; Popli H; Bhatnagar A Chem Phys Lipids; 2021 May; 236():105060. PubMed ID: 33582127 [TBL] [Abstract][Full Text] [Related]
36. Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution. Battaglia L; Serpe L; Muntoni E; Zara G; Trotta M; Gallarate M Nanomedicine (Lond); 2011 Nov; 6(9):1561-73. PubMed ID: 22011315 [TBL] [Abstract][Full Text] [Related]
37. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, Patel MH; Mundada VP; Sawant KK Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488 [No Abstract] [Full Text] [Related]
38. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation. Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712 [TBL] [Abstract][Full Text] [Related]
39. Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway. Wang J; Zhu R; Sun X; Zhu Y; Liu H; Wang SL Int J Nanomedicine; 2014; 9():3987-98. PubMed ID: 25187702 [TBL] [Abstract][Full Text] [Related]
40. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. Graverini G; Piazzini V; Landucci E; Pantano D; Nardiello P; Casamenti F; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC Colloids Surf B Biointerfaces; 2018 Jan; 161():302-313. PubMed ID: 29096375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]